Azam Amirian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Azam Amirian has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Fatemeh Abdi
Nursing and Midwifery Care Research Center, Health Management Research Institute, Iran University of Medical Sciences, Tehran, Iran
5 shared publications - Anoshirvan Kazemnejad
Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University
2 shared publications - Maedeh Amini
Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Mahin Balouchi Mahani
Department of Midwifery, School of Nursing and Midwifery, Jiroft University of Medical Sciences, Jirof, Iran
2 shared publications- Masoumeh Simbar
Midwifery and Reproductive Health Research Center, Department of Midwifery and Reproductive Health, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran
2 shared publications Nourossadat Kariman
Department of Midwifery and Reproductive Health, School of Nursing and Midwifery Shahid Beheshti University of Medical Sciences Tehran Iran
2 shared publications
Latest Publications
- 8 May 2026
- Published by Elsevier in Public Health
- Vol. 256, 106264
Non-sexual transmission modes of human papillomavirus in women: A systematic review
- 8 May 2026
- Published by Elsevier in Public Health
- Vol. 256, 106264
Non-sexual transmission modes of human papillomavirus in women: A systematic review
- Open Access
- 23 February 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
The association of psycho-economic factors with postpartum depression without significant medical complications for the mother and infant: a systematic review and meta-analysis
Postpartum depression (PPD) is a significant mood disorder affecting mothers during the postpartum period. Multiple factors, including biological, psycholo
- 23 February 2026
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 26 (1)
Open AccessThe association of psycho-economic factors with postpartum depression without significant medical complications for the mother and infant: a systematic review and meta-analysis
Postpartum depression (PPD) is a significant mood disorder affecting mothers during the postpartum period. Multiple factors, including biological, psycholo
- Open Access
- 10 November 2024
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 11 (4)
The Predictive Power of the Mother’s Neck Circumference in the Early Diagnosis of Gestational Diabetes Mellitus
Background: Gestational diabetes mellitus (GDM) is a risk factor for the health of both the mother and fetus, responsible for a significant number of maternal, perinatal, and neonatal complications. Timely diagnosis and effective treatment can reduce the burden of the disease on the health of women and their infants during and after pregnancy. Objectives: The present study aimed to examine the predictive power of the mother’s neck circumference in the early diagnosis of gestational diabetes mellitus. Methods: This prospective cohort study was conducted on 782 pregnant women with a gestational age of 16 weeks who visited health centers in Jiroft between 2020 and 2021. Neck circumference was measured in the 16th week of pregnancy. Gestational diabetes mellitus was diagnosed using an oral glucose tolerance test (OGTT) with 75 grams of glucose at 24-28 weeks of pregnancy. Participants were selected using convenience sampling, and data were collected through interviews with the participants. Results: Among the 782 pregnant women, 179 were diagnosed with GDM, while 603 did not have GDM. The best cut-off point for neck size was determined to be 35.45 cm using the ROC curve. For the neck circumference test, sensitivity was 71.5%, specificity was 60%, positive predictive value was 34.8%, and negative predictive value was 87.7%. Conclusions: The findings indicate that a neck circumference greater than 35.45 cm in early pregnancy (16 weeks) can be considered a new diagnostic test for GDM. Early identification of women at risk should prompt necessary measures to reduce the complications associated with gestational diabetes mellitus.
- 10 November 2024
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 11 (4)
Open AccessThe Predictive Power of the Mother’s Neck Circumference in the Early Diagnosis of Gestational Diabetes Mellitus
Background: Gestational diabetes mellitus (GDM) is a risk factor for the health of both the mother and fetus, responsible for a significant number of maternal, perinatal, and neonatal complications. Timely diagnosis and effective treatment can reduce the burden of the disease on the health of women and their infants during and after pregnancy. Objectives: The present study aimed to examine the predictive power of the mother’s neck circumference in the early diagnosis of gestational diabetes mellitus. Methods: This prospective cohort study was conducted on 782 pregnant women with a gestational age of 16 weeks who visited health centers in Jiroft between 2020 and 2021. Neck circumference was measured in the 16th week of pregnancy. Gestational diabetes mellitus was diagnosed using an oral glucose tolerance test (OGTT) with 75 grams of glucose at 24-28 weeks of pregnancy. Participants were selected using convenience sampling, and data were collected through interviews with the participants. Results: Among the 782 pregnant women, 179 were diagnosed with GDM, while 603 did not have GDM. The best cut-off point for neck size was determined to be 35.45 cm using the ROC curve. For the neck circumference test, sensitivity was 71.5%, specificity was 60%, positive predictive value was 34.8%, and negative predictive value was 87.7%. Conclusions: The findings indicate that a neck circumference greater than 35.45 cm in early pregnancy (16 weeks) can be considered a new diagnostic test for GDM. Early identification of women at risk should prompt necessary measures to reduce the complications associated with gestational diabetes mellitus.
- Open Access
- 29 September 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (10)
Early prediction of gestational diabetes mellitus using first trimester maternal serum pregnancy‐associated plasma protein‐a: A cross‐sectional study
Background and Aims: The oral glucose tolerance test with 75 g glucose is commonly regarded as the gold standard (GS) for the detection of gestational diabetes mellitus (GDM). However, one limitation of this test is its administration in the late second trimester of pregnancy in some countries (e.g., Iran). This study aimed to evaluate the accuracy of pregnancy‐associated plasma protein‐A (PAPP‐A) for predicting GDM in the early first trimester of pregnancy using a novel statistical modeling technique.Methods: The study population consisted of 344 pregnant women who participated in the first trimester screening program for GDM. Maternal serum PAPP‐A levels were measured between 11 and 13 gestational weeks for all participants. A Bayesian latent profile model (LPM) under the skew‐t (ST) distribution was employed to estimate the diagnostic accuracy measures of PAPP‐A in the absence of GS test outcomes.Results: The mean (standard deviation) age of the participants was 28.87 ± 5.20 years. The median (interquartile range (IQR)) PAPP‐A MoM was 0.91 (0.69‐1.34). Utilizing the LPM under the ST distribution while adjusting for covariates, the sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of PAPP‐A were 92% (95% credible interval [CrI]: 0.89, 0.98), 81% (95% CrI: 0.76, 0.91), and 0.91 (95% CrI: 0.83, 0.97), respectively. Notably, the pregnant women with GDM had significantly lower PAPP‐A values ( −0.52, 95% CrI [−0.61, −0.46]).Conclusion: Generally, our findings confirmed that PAPP‐A could serve as a potential screening tool for the identification of GDM in the early stages of pregnancy.
- 29 September 2024
- Published by Wiley in Health Science Reports
- Vol. 7 (10)
Open AccessEarly prediction of gestational diabetes mellitus using first trimester maternal serum pregnancy‐associated plasma protein‐a: A cross‐sectional study
Background and Aims: The oral glucose tolerance test with 75 g glucose is commonly regarded as the gold standard (GS) for the detection of gestational diabetes mellitus (GDM). However, one limitation of this test is its administration in the late second trimester of pregnancy in some countries (e.g., Iran). This study aimed to evaluate the accuracy of pregnancy‐associated plasma protein‐A (PAPP‐A) for predicting GDM in the early first trimester of pregnancy using a novel statistical modeling technique.Methods: The study population consisted of 344 pregnant women who participated in the first trimester screening program for GDM. Maternal serum PAPP‐A levels were measured between 11 and 13 gestational weeks for all participants. A Bayesian latent profile model (LPM) under the skew‐t (ST) distribution was employed to estimate the diagnostic accuracy measures of PAPP‐A in the absence of GS test outcomes.Results: The mean (standard deviation) age of the participants was 28.87 ± 5.20 years. The median (interquartile range (IQR)) PAPP‐A MoM was 0.91 (0.69‐1.34). Utilizing the LPM under the ST distribution while adjusting for covariates, the sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) of PAPP‐A were 92% (95% credible interval [CrI]: 0.89, 0.98), 81% (95% CrI: 0.76, 0.91), and 0.91 (95% CrI: 0.83, 0.97), respectively. Notably, the pregnant women with GDM had significantly lower PAPP‐A values ( −0.52, 95% CrI [−0.61, −0.46]).Conclusion: Generally, our findings confirmed that PAPP‐A could serve as a potential screening tool for the identification of GDM in the early stages of pregnancy.
- Open Access
- 18 September 2023
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 10 (4)
The Impact of Ethical Leadership on the Nursing Profession in Iran: A Systematic Review
Introduction: Ethical leadership plays a key role in professional settings. Nurses play an essential role in care provision and health promotion. The present study aimed to determine the impact of ethical leadership on the nursing profession in Iran. The objective of this study was the assessment of the relationship between ethical leadership and the improvement of clinical services by nurses. Methods: Terms defined as MESH keywords were searched in PubMed, Scopus, ProQuest, SID, and Magiran up to October 2022. In this study, only observational and qualitative studies were selected and included. Results: A total of 16 studies met the inclusion criteria. The results showed the association of ethical leadership with moral courage, self-efficacy, turnover, general health, errors, organizational citizenship, moral distress, job satisfaction, stress, risk management, and psychological empowerment. It was shown that ethical leadership is in direct association with nursing performance. Conclusions: The present study confirmed the positive effect of nursing ethical leadership on the nursing profession. Further studies are needed to examine the association between ethical leadership and clinical outcomes in patients.
- 18 September 2023
- Published by Brieflands in Journal of Nursing and Midwifery Sciences
- Vol. 10 (4)
Open AccessThe Impact of Ethical Leadership on the Nursing Profession in Iran: A Systematic Review
Introduction: Ethical leadership plays a key role in professional settings. Nurses play an essential role in care provision and health promotion. The present study aimed to determine the impact of ethical leadership on the nursing profession in Iran. The objective of this study was the assessment of the relationship between ethical leadership and the improvement of clinical services by nurses. Methods: Terms defined as MESH keywords were searched in PubMed, Scopus, ProQuest, SID, and Magiran up to October 2022. In this study, only observational and qualitative studies were selected and included. Results: A total of 16 studies met the inclusion criteria. The results showed the association of ethical leadership with moral courage, self-efficacy, turnover, general health, errors, organizational citizenship, moral distress, job satisfaction, stress, risk management, and psychological empowerment. It was shown that ethical leadership is in direct association with nursing performance. Conclusions: The present study confirmed the positive effect of nursing ethical leadership on the nursing profession. Further studies are needed to examine the association between ethical leadership and clinical outcomes in patients.
- 4 January 2022
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 9234-9248
Neonatal outcome among pregnant women with COVID-19: a systematic review and meta-analysis
COVID-19 has raised many concerns about the possible side effects of pregnancy. There is currently no conclusive evidence of the vertical transmission of COVID-19. Accordingly, this paper is a Syst...
- 4 January 2022
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 9234-9248
Neonatal outcome among pregnant women with COVID-19: a systematic review and meta-analysis
COVID-19 has raised many concerns about the possible side effects of pregnancy. There is currently no conclusive evidence of the vertical transmission of COVID-19. Accordingly, this paper is a Syst...
- Open Access
- 22 December 2021
- Published by European Publishing in European Journal of Midwifery
- Vol. 5 (December) , 1-9
Iranian midwives’ awareness and performance of respectful maternity care during labor and childbirth
Introduction: Midwives’ perceptions of Respectful Maternity Care (RMC) play an important role in promoting quality of care. This study aimed to explore the awareness and performance of Iranian midwives of RMC during childbirth. Methods: A cross-sectional study was carried out from November...
- 22 December 2021
- Published by European Publishing in European Journal of Midwifery
- Vol. 5 (December) , 1-9
Open AccessIranian midwives’ awareness and performance of respectful maternity care during labor and childbirth
Introduction: Midwives’ perceptions of Respectful Maternity Care (RMC) play an important role in promoting quality of care. This study aimed to explore the awareness and performance of Iranian midwives of RMC during childbirth. Methods: A cross-sectional study was carried out from November...
- Open Access
- 1 August 2020
- Vol. 22 (6) , 670-671
Diagnosis of SARS-CoV-2 Vertical Transmission Using the Amniotic Fluid Test
- 1 August 2020
- Vol. 22 (6) , 670-671
Open AccessDiagnosis of SARS-CoV-2 Vertical Transmission Using the Amniotic Fluid Test
- Open Access
- 15 July 2020
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 63 (4) , 407-416
Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus
Gestational diabetes mellitus (GDM) is the most common pregnancy-associated metabolic disorder that is steadily increasing worldwide. Early diagnosis of pregnant women susceptible to GDM is the first step for deploying effective preventive treatment to reduce maternal, fetal, and neonatal complications. The diagnostic process of GDM is still controversial and interleukin-6 (IL-6) is one of the most recent markers used for the diagnosis of GDM. In this study, we aimed to systematically review the role of IL-6 in the diagnosis of GDM. In this systematic review, Google Scholar, Scopus, PubMed, ISI Web of Science, ProQuest, and MEDLINE databases were searched using the following keywords: GDM, screening, and IL-6, with the time interval 2009-2020. The quality of articles was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology checklist. Twenty-four articles with desired quality that met the inclusion criteria were selected and reviewed further. Sixteen studies showed a statistically significant association, while 8 studies did not report any relationship between IL-6 levels and GDM. Based on the results of these studies, assessing the serum IL-6 levels can be investigated a newly established diagnostic biomarker for GDM. Therefore, through early diagnosis of susceptible women, effective measures can be implemented to reduce its complications.
- 15 July 2020
- Published by Korean Society of Obstetrics and Gynecology in Obstetrics & Gynecology Science
- Vol. 63 (4) , 407-416
Open AccessRole of interleukin-6 (IL-6) in predicting gestational diabetes mellitus
Gestational diabetes mellitus (GDM) is the most common pregnancy-associated metabolic disorder that is steadily increasing worldwide. Early diagnosis of pregnant women susceptible to GDM is the first step for deploying effective preventive treatment to reduce maternal, fetal, and neonatal complications. The diagnostic process of GDM is still controversial and interleukin-6 (IL-6) is one of the most recent markers used for the diagnosis of GDM. In this study, we aimed to systematically review the role of IL-6 in the diagnosis of GDM. In this systematic review, Google Scholar, Scopus, PubMed, ISI Web of Science, ProQuest, and MEDLINE databases were searched using the following keywords: GDM, screening, and IL-6, with the time interval 2009-2020. The quality of articles was assessed using the Strengthening the Reporting of Observational Studies in Epidemiology checklist. Twenty-four articles with desired quality that met the inclusion criteria were selected and reviewed further. Sixteen studies showed a statistically significant association, while 8 studies did not report any relationship between IL-6 levels and GDM. Based on the results of these studies, assessing the serum IL-6 levels can be investigated a newly established diagnostic biomarker for GDM. Therefore, through early diagnosis of susceptible women, effective measures can be implemented to reduce its complications.
- Open Access
- 26 June 2020
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 20 (1) , 1-9
Diagnostic accuracy of maternal serum multiple marker screening for early detection of gestational diabetes mellitus in the absence of a gold standard test
Background: Gestational diabetes mellitus (GDM) is associated with adverse diabetic complications for both mother and child during pregnancy. The common Gold Standard (GS) for diagnosis of GDM is 75 g oral glucose tolerance test (OGTT) during 24–28 gestational weeks which seems a little late for any proper intervention. This study aimed to employ the Bayesian latent class models (LCMs) for estimating the early diagnostic power of combination of serum multiple marker in detecting GDM during 14–17 weeks of gestation. Methods: Data from a sample of 523 pregnant women who participated in gestational diabetes screening tests at health centers affiliated to Shahid Beheshti University of Medical Sciences in Tehran, Iran from 2017 to 2018 were used. The beta-human chorionic gonadotropin (β-hCG), unconjugated estriol (uE3), and alfa-fetoprotein (AFP) values were extracted from case records for all participants. The Bayesian LCMs were applied for estimating sensitivity, specificity, and area under receiver operating characteristic curve (AUC) of combining the three biomarkers’ results in the absence of GS, adjusting for maternal age and body mass index. Results: The mean (standard deviation) maternal age of the participants was 28.76 (±5.33) years. Additionally, the mean (standard deviation) BMI was 24.57 (±3.22) kg/m2. According to the Bayesian model, the cSensitivity, cSpecificity, and cAUC for the optimal composite diagnostic test were estimated as 94% (95% credible interval (CrI) [0.91–0.99]), 86% (95% CrI [0.80–0.92]), and 0.92 (95% CrI [0.87–0.98]), respectively. Conclusions: Overall, the findings revealed that the combination of uE3, AFP, and β-hCG results might be considered as an acceptable predictor for detecting GDM with a rather high level of accuracy in the early second trimester of pregnancy without a GS.
- 26 June 2020
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 20 (1) , 1-9
Open AccessDiagnostic accuracy of maternal serum multiple marker screening for early detection of gestational diabetes mellitus in the absence of a gold standard test
Background: Gestational diabetes mellitus (GDM) is associated with adverse diabetic complications for both mother and child during pregnancy. The common Gold Standard (GS) for diagnosis of GDM is 75 g oral glucose tolerance test (OGTT) during 24–28 gestational weeks which seems a little late for any proper intervention. This study aimed to employ the Bayesian latent class models (LCMs) for estimating the early diagnostic power of combination of serum multiple marker in detecting GDM during 14–17 weeks of gestation. Methods: Data from a sample of 523 pregnant women who participated in gestational diabetes screening tests at health centers affiliated to Shahid Beheshti University of Medical Sciences in Tehran, Iran from 2017 to 2018 were used. The beta-human chorionic gonadotropin (β-hCG), unconjugated estriol (uE3), and alfa-fetoprotein (AFP) values were extracted from case records for all participants. The Bayesian LCMs were applied for estimating sensitivity, specificity, and area under receiver operating characteristic curve (AUC) of combining the three biomarkers’ results in the absence of GS, adjusting for maternal age and body mass index. Results: The mean (standard deviation) maternal age of the participants was 28.76 (±5.33) years. Additionally, the mean (standard deviation) BMI was 24.57 (±3.22) kg/m2. According to the Bayesian model, the cSensitivity, cSpecificity, and cAUC for the optimal composite diagnostic test were estimated as 94% (95% credible interval (CrI) [0.91–0.99]), 86% (95% CrI [0.80–0.92]), and 0.92 (95% CrI [0.87–0.98]), respectively. Conclusions: Overall, the findings revealed that the combination of uE3, AFP, and β-hCG results might be considered as an acceptable predictor for detecting GDM with a rather high level of accuracy in the early second trimester of pregnancy without a GS.